Advanced search
Publication Cover
Platelets Volume 22, 2011 - Issue 6
Submit an article Journal homepage
529
Views
41
CrossRef citations to date
0
Altmetric
Review

Genetic determinants of on-clopidogrel high platelet reactivity

Gianluca CampoCardiovascular Institute, Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS, Lumezzane (BS), Italy and LTTA Center, Ferrara, ItalyCorrespondence[email protected]
,
Matteo MiccoliCardiovascular Institute, Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS, Lumezzane (BS), Italy and LTTA Center, Ferrara, Italy
,
Matteo TebaldiCardiovascular Institute, Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS, Lumezzane (BS), Italy and LTTA Center, Ferrara, Italy
,
Jlenia MarchesiniCardiovascular Institute, Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS, Lumezzane (BS), Italy and LTTA Center, Ferrara, Italy
,
Luca FiletiCardiovascular Institute, Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS, Lumezzane (BS), Italy and LTTA Center, Ferrara, Italy
,
Monia MontiCardiovascular Institute, Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS, Lumezzane (BS), Italy and LTTA Center, Ferrara, Italy
,
Marco ValgimigliCardiovascular Institute, Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS, Lumezzane (BS), Italy and LTTA Center, Ferrara, Italy
&
Roberto FerrariCardiovascular Institute, Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy and Cardiovascular Research Centre, Salvatore Maugeri Foundation, IRCCS, Lumezzane (BS), Italy and LTTA Center, Ferrara, Italy
 show all
Pages 399-407 | Received 29 Jan 2011, Accepted 05 Apr 2011, Published online: 31 May 2011

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Yulun Cai, Weihao Xu, Hongbin Liu, Fan Wang, Lei Duan, Huiying Li, Man Li, Yuerui Li, Lina Han & Hunan Xiao. (2020) Effects of cigarette smoking on older chinese men treated with clopidogrel monotherapy or aspirin monotherapy: a prospective study. Platelets 31:5, pages 667-673.
Read now
Susan C. Fox, Jane A. May, Natalia Dovlatova, Jackie R. Glenn, Andrew Johnson, Ann E. White, Ashwin Radhakrishnan & Stan Heptinstall. (2019) How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?. Platelets 30:3, pages 290-295.
Read now
Hanna Ratcovich, Lene Holmvang, Pär Inge Johansson & Nadia Parup Dridi. (2016) Traditional clinical risk factors predict clopidogrel hypo-responsiveness in unselected patients undergoing non-emergent percutaneous coronary intervention. Platelets 27:1, pages 51-58.
Read now
Marc Laine, Corinne Frere, Olivia Ronsin, Melanie Gaubert, Richard Toesca, Jacques Bessereau, Pierre Michelet, Catherine Gramond, Olfa Helal, Franck Paganelli & Laurent Bonello. (2013) Assessing post-treatment platelet reactivity: a focus on patient selection and setting. Expert Review of Cardiovascular Therapy 11:11, pages 1557-1566.
Read now
Srinivas Yallapragada, Saifullah Siddiqui, Ryan Gindi & Adhir Shroff. (2013) Adherence to dual antiplatelet therapy: can we do better?. Expert Review of Cardiovascular Therapy 11:10, pages 1417-1424.
Read now
Chun Shing Kwok & Yoon Kong Loke. (2012) Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors. Expert Opinion on Drug Safety 11:2, pages 275-284.
Read now

Articles from other publishers (35)

Jonathan Shpigelman, Anastasia Proshkina, Michael J. Daly & Dermot Cox. (2023) Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis. Current Cardiology Reports 25:7, pages 693-710.
Crossref
Adel Alhazzani, Poongothai Venkatachalapathy, Sruthi Padhilahouse, Mohan Sellappan, Murali Munisamy, Mangaiyarkarasi Sekaran & Amit Kumar. (2021) Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review. Frontiers in Neurology 12.
Crossref
Urszula Adamiak-Giera, Anna Czerkawska, Szymon Olędzki, Mateusz Kurzawski, Krzysztof Safranow, Maria Jastrzębska & Barbara Gawrońska-Szklarz. (2020) Impact of selected genetic factors on clopidogrel inactive metabolite level and antiplatelet response in patients after percutaneous coronary intervention. Pharmacological Reports 73:2, pages 583-593.
Crossref
Jieyun You, Hongda Li, Wei Guo, Jiming Li, Liming Gao, Yunkai Wang, Liang Geng, Xingxu Wang, Qing Wan & Qi Zhang. (2020) Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST‐segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study. Catheterization and Cardiovascular Interventions 95:S1, pages 598-605.
Crossref
Даниил Георгиевич Гительзон, Александр Георгиевич Файбушевич, Даниил Александрович Максимкин, Галина Ивановна Веретник, Владислав Юрьевич Баранович, Екатерина Александровна Гительзон, Александр Эдуардович Васильев & Карен Исмаилович Данишян. (2020) Персонализированная антитромботическая терапия при стентировании коронарных артерий. Естественные и Технические Науки:№10, pages 144-150.
Crossref
D. G. Gitelson, A. G. Faibushevich, D. A. Maximkin, G. I. Veretnik, A. E. Vasiliev, E. A. Gitelzon, D. A. Rogov & K. I. Danishian. (2019) Effectiveness of personalized antiplatelet therapy in patients undergoing coronary stenting: meta-analysis. Complex Issues of Cardiovascular Diseases 8:4, pages 26-36.
Crossref
Brittney H Davis, Chrisly Dillon, Anping Cai, Lance A Williams III, Salpy V Pamboukian & Nita A Limdi. (2019) Between a rock and a hard place: a high-risk patient with resistance to multiple P2Y 12 antagonists . Pharmacogenomics 20:7, pages 475-481.
Crossref
Peng Ding, Yujie Wei, Nana Chen & Huiliang Liu. (2017) Validation of a New ELISA-Based Vasodilator-Associated Stimulated Phosphoprotein Phosphorylation Assay to Assess Platelet Reactivity Index in a Chinese Population. Clinical and Applied Thrombosis/Hemostasis 24:3, pages 452-461.
Crossref
Szilvia Fiatal & Róza Ádány. (2018) Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review. Frontiers in Public Health 5.
Crossref
Yasushi Nagao, Rikuo Masuda, Akane Ando, Mutsumi Nonaka, Akiko Nishimura, Kinuko Goto, Yasubumi Maruoka & Takehiko Iijima. (2017) Whole Blood Platelet Aggregation Test and Prediction of Hemostatic Difficulty After Tooth Extraction in Patients Receiving Antiplatelet Therapy. Clinical and Applied Thrombosis/Hemostasis 24:1, pages 151-156.
Crossref
Yijiang Zhou, Yanwei Wang, Yutao Wu, Chaoyang Huang, Hui Yan, Weiguo Zhu, Weiwei Xu, Li Zhang & Jianhua Zhu. (2017) Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders 17:1.
Crossref
Lichen Zhang, Xiaowei Ma, Guoling You, Xiaoqing Zhang & Qihua Fu. (2017) A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance. Scientific Reports 7:1.
Crossref
López-Hernández Daniel. (2017) Polymorphisms of cytochrome P450 are potential candidates that could potentially help clinicians on the treatment of cardiovascular diseases among Asian populations. Indian Heart Journal 69:5, pages 655-656.
Crossref
Ana Vavlukis, Aleksandra Kapedanovska Nestorovska, Zoran Sterjev, Aleksandra Grozdanova, Marija Vavlukis & Zorica Naumovska. (2017) Influence of ABCB1 C3435T Genotype on Clinical Cardiovascular Outcomes in Coronary Artery Disease Patients on Clopidogrel Treatment. MOJ Drug Design Development & Therapy 1:2.
Crossref
M. Zaiou & H. El Amri. (2016) Cardiovascular pharmacogenetics: a promise for genomically‐guided therapy and personalized medicine. Clinical Genetics 91:3, pages 355-370.
Crossref
Mohammad Algahtani & Stan Heptinstall. (2017) Novel strategies for assessing platelet reactivity. Future Cardiology 13:1, pages 33-47.
Crossref
Roberto Ferrari & Gianluca Campo. (2017) Operator, Drug or Device: Who Will Break Down Acute Stent Thrombosis?. Cardiology 137:4, pages 244-245.
Crossref
K. Kukula, M. Klopotowski, P. K. Kunicki, J. Jamiolkowski, A. Debski, P. Bekta, M. Polanska-Skrzypczyk, Z. Chmielak & A. Witkowski. (2016) Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome. BMC Cardiovascular Disorders 16:1.
Crossref
Shu Zhang, Changli Sun, Hai Hu, Yarong He, Yuanchang Yao, Yu Cao & Zhi Zeng. (2016) Effects of Paclitaxel on the Ability of Aspirin and Clopidogrel to Inhibit Platelet Aggregation. Clinical and Applied Thrombosis/Hemostasis 22:7, pages 673-678.
Crossref
Yingting Wang, Huan Cai, Guoqing Zhou, Zhizhong Zhang & Xinfeng Liu. (2016) Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel. Journal of the Neurological Sciences 369, pages 216-219.
Crossref
Chanjuan Cui, Rui Qiao & Jie Zhang. (2015) Monitoring Residual Platelet Activity Among Patients With Acute Coronary Syndrome Post-PCI by Modified Impedance Whole Blood Platelet Aggregation and Release Method. Clinical and Applied Thrombosis/Hemostasis 22:4, pages 366-371.
Crossref
Adrien Harvey, Anil Modak, Ugo Déry, Mélanie Roy, Stéphane Rinfret, Olivier F Bertrand, Éric Larose, Josep Rodés-Cabau, Gérald Barbeau, Onil Gleeton, Can Manh Nguyen, Guy Proulx, Bernard Noël, Louis Roy, Jean-Michel Paradis, Robert De Larochellière & Jean-Pierre Déry. (2016) Changes in CYP2C19 enzyme activity evaluated by the [ 13 C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity . Journal of Breath Research 10:1, pages 017104.
Crossref
Priyanka Bajaj, Rajan K. Tripathy, Geetika Aggarwal & Abhay H. Pande. (2015) Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli. Protein Expression and Purification 115, pages 95-101.
Crossref
Gianluca Campo, Rita Pavasini, Simone Biscaglia, Alessandra Ferri, Elisa Andrenacci, Matteo Tebaldi & Roberto Ferrari. (2015) Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study. Pharmacological Research 97, pages 1-6.
Crossref
Li-Na Qiu, Lin Wang, Xin Li, Rui-Fa Han, Xiao-Shuang Xia & Jie Liu. (2015) Predictive Value of High Residual Platelet Reactivity by Flow Cytometry for Outcomes of Ischemic Stroke Patients on Clopidogrel Therapy. Journal of Stroke and Cerebrovascular Diseases 24:6, pages 1145-1152.
Crossref
Marian Fedor, M. Samoš, R. Šimonová, J. Fedorová, I. Škorňová, L. Duraj, J. Staško, F. Kovář, M. Mokáň & P. Kubisz. (2014) Monitoring the Efficacy of ADP Inhibitor Treatment in Patients With Acute STEMI Post-PCI by VASP-P Flow Cytometry Assay. Clinical and Applied Thrombosis/Hemostasis 21:4, pages 334-338.
Crossref
Hanbin Cui, Shaoyi Lin, Xiaomin Chen, Wenhui Gao, Xiaojing Li, Honglin Zhou, Weiping Du, Shenghuang Wang & Ruochi Zhao. (2015) Correlation Between SNPs in Candidate Genes and VerifyNow-Detected Platelet Responsiveness to Aspirin and Clopidogrel Treatment. Cardiovascular Drugs and Therapy 29:2, pages 137-146.
Crossref
Li-Na Qiu, Yan Sun, Lin Wang, Rui-Fa Han, Xiao-Shuang Xia, Jie Liu & Xin Li. (2015) Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. European Journal of Pharmacology 747, pages 29-35.
Crossref
Rasmus Steen Pedersen, Flemming Nielsen, Tore Bjerregaard Stage, Pernille Just Vinholt, Alaa Bilal el Achwah, Per Damkier & Kim Brosen. (2014) CYP2C19*17 increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel . Clinical and Experimental Pharmacology and Physiology 41:11, pages 870-878.
Crossref
Rajendran Priyadharsini, Deepak Gopal Shewade, Kumaresan Subraja, Byrappa Kempalalakshmamma Ravindra, Gurusamy Umamaheswaran, Steven Aibor Dkhar, Santhosh Satheesh, Magadi Gopalakrishna Sridhar, Sunil K. Narayan & Chandrasekaran Adithan. (2014) Single nucleotide polymorphism of CYP3A5*3 contributes to clopidogrel resistance in coronary artery disease patients among Tamilian population. Molecular Biology Reports 41:11, pages 7265-7271.
Crossref
Vacis Tatarunas, Laima Jankauskiene, Nora Kupstyte, Vilius Skipskis, Olivija Gustiene, Pranas Grybauskas & Vaiva Lesauskaite. (2014) The role of clinical parameters and of CYP2C19 G681 and CYP4F2 G1347A polymorphisms on platelet reactivity during dual antiplatelet therapy. Blood Coagulation & Fibrinolysis 25:4, pages 369-374.
Crossref
Priyanka Bajaj, Rajan K. Tripathy, Geetika Aggarwal & Abhay H. Pande. (2014) Human Paraoxonase 1 as a Pharmacologic Agent: Limitations and Perspectives. The Scientific World Journal 2014, pages 1-6.
Crossref
Thomas Cuisset, Pierre-Emmanuel Morange & Marie-Christine Alessi. (2011) Recent advances in the pharmacogenetics of clopidogrel. Human Genetics 131:5, pages 653-664.
Crossref
Soha Namazi, Javad Kojuri, Andia Khalili & Negar Azarpira. (2012) The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients. Biochemical Pharmacology 83:7, pages 903-908.
Crossref
Giovanni de Gaetano, Iolanda Santimone, Francesco Gianfagna, Licia Iacoviello & Chiara Cerletti. 2012. Antiplatelet Agents. Antiplatelet Agents 395 434 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.